Page last updated: 2024-08-21

methylnitrosourea and Barrett Esophagus

methylnitrosourea has been researched along with Barrett Esophagus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bao, C; Bass, AJ; Beroukhim, R; Bronson, R; Duronio, GN; Ferrer-Luna, R; Kikuchi, O; Lazaro, JB; Ligon, KL; Liu, JB; McFarland, JM; Patil, D; Sanchez-Vega, F; Sethi, NS; Sicinska, E; Stachler, MD; Zhang, Y	1

Other Studies

1 other study(ies) available for methylnitrosourea and Barrett Esophagus

Article	Year
Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model. Nature genetics, 2020, Volume: 52, Issue:2 Topics: Adenocarcinoma; Animals; Barrett Esophagus; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Environmental Exposure; Esophageal Neoplasms; Humans; Methylnitrosourea; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Neoplasms, Experimental; Organoids; Precancerous Conditions; Stomach Neoplasms; Tumor Suppressor Protein p53	2020

Article

Year

Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.

Nature genetics, 2020, Volume: 52, Issue:2

Topics: Adenocarcinoma; Animals; Barrett Esophagus; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Environmental Exposure; Esophageal Neoplasms; Humans; Methylnitrosourea; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Neoplasms, Experimental; Organoids; Precancerous Conditions; Stomach Neoplasms; Tumor Suppressor Protein p53

2020